In conclusion, this meta-analysis evaluates the relation-ship between genetic polymorphism and CRC risk and reveals that CYP2C9 *2 and *3 polymorphism is not associated with altered susceptibility to CRC. Here, CYP2C9 is linked to colorectal carcinoma.